Subsequent Event (Details) - USD ($) $ / shares in Units, $ in Millions |
Oct. 30, 2026 |
Nov. 02, 2026 |
Oct. 31, 2026 |
Aug. 01, 2026 |
|---|---|---|---|---|
| Acquisition Term Loan | Unsecured Debt | Invidior Pharmaceuticals, Inc. | ||||
| Subsequent Event [Line Items] | ||||
| Commitments to extend credit | $ 650 | |||
| Subsequent Event | ||||
| Subsequent Event [Line Items] | ||||
| Common stock, dividends, per share, declared (in dollars per share) | $ 8.13 | |||
| Subsequent Event | ONAPGO | Patents | ||||
| Subsequent Event [Line Items] | ||||
| Estimated useful lives | 7 years | |||
| Subsequent Event | Acquisition Term Loan | Unsecured Debt | Invidior Pharmaceuticals, Inc. | ||||
| Subsequent Event [Line Items] | ||||
| Commitments to extend credit | $ 650 |